Cargando…
Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview
Novel drug delivery systems for controlled-release of opioid agonists as a long time painkillers or opioid antagonists for opium, heroin, and alcohol addiction are under development or in clinical use today. In this article, the field of “new drug delivery systems” is momentarily reviewed from the v...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115645/ https://www.ncbi.nlm.nih.gov/pubmed/27882209 |
_version_ | 1782468542407376896 |
---|---|
author | Soltani, Hoda Pardakhty, Abbas |
author_facet | Soltani, Hoda Pardakhty, Abbas |
author_sort | Soltani, Hoda |
collection | PubMed |
description | Novel drug delivery systems for controlled-release of opioid agonists as a long time painkillers or opioid antagonists for opium, heroin, and alcohol addiction are under development or in clinical use today. In this article, the field of “new drug delivery systems” is momentarily reviewed from the viewpoint of the marketed opioid agonists/antagonists dosage forms today. |
format | Online Article Text |
id | pubmed-5115645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-51156452016-11-23 Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview Soltani, Hoda Pardakhty, Abbas Addict Health Review Article Novel drug delivery systems for controlled-release of opioid agonists as a long time painkillers or opioid antagonists for opium, heroin, and alcohol addiction are under development or in clinical use today. In this article, the field of “new drug delivery systems” is momentarily reviewed from the viewpoint of the marketed opioid agonists/antagonists dosage forms today. Kerman University of Medical Sciences 2016-04 /pmc/articles/PMC5115645/ /pubmed/27882209 Text en © 2016 Kerman University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Review Article Soltani, Hoda Pardakhty, Abbas Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview |
title | Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview |
title_full | Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview |
title_fullStr | Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview |
title_full_unstemmed | Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview |
title_short | Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview |
title_sort | marketed new drug delivery systems for opioid agonists/antagonists administration: a rapid overview |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115645/ https://www.ncbi.nlm.nih.gov/pubmed/27882209 |
work_keys_str_mv | AT soltanihoda marketednewdrugdeliverysystemsforopioidagonistsantagonistsadministrationarapidoverview AT pardakhtyabbas marketednewdrugdeliverysystemsforopioidagonistsantagonistsadministrationarapidoverview |